Emergent BioSolutions Inc.（EBS）内部人交易：高管与董事近期交易
过去 18 个月，共有 17 位内部人为 Emergent BioSolutions Inc.（EBS）报告了 79 笔 Form 4 交易（最近一笔 2026-10-07）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-07 | DeGolyer Donald W | 董事 | 卖出 | 17,800 | $126,202 |
| 2026-10-05 | Williams Paul Anthony | SVP, Products Business | 卖出 | 3,000 | $19,590 |
| 2026-07-02 | Williams Paul Anthony | SVP, Products Business | 卖出 | 3,000 | $25,200 |
| 2026-06-10 | Williams Paul Anthony | SVP, Products Business | 卖出 | 694 | $5,552 |
| 2026-06-10 | Glessner Coleen | EVP, Quality & Ethics, and CPL | 卖出 | 2,018 | $16,144 |
| 2026-06-10 | LINDAHL RICHARD S | EVP, Chief Financial Officer | 卖出 | 3,964 | $31,712 |
| 2026-06-10 | Hartzel William | SVP, Bioservices | 卖出 | 1,741 | $13,928 |
| 2026-05-04 | Dayal Sujata Tyagi | 董事 | 买入 | 25,344 | $0 |
| 2026-05-04 | Fowler Neal Franklin | 董事 | 买入 | 25,344 | $0 |
| 2026-05-04 | Richard Ronald | 董事 | 买入 | 25,344 | $0 |
| 2026-05-04 | Katkin Keith | 董事 | 买入 | 25,344 | $0 |
| 2026-05-04 | Katkin Keith | 董事 | 卖出 | 15,481 | $128,183 |
| 2026-05-04 | White Marvin L | 董事 | 买入 | 25,344 | $0 |
| 2026-05-04 | Dayal Sujata Tyagi | 董事 | 卖出 | 12,781 | $106,849 |
| 2026-05-04 | Dayal Sujata Tyagi | 董事 | 卖出 | 980 | $8,761 |
| 2026-05-04 | FOWLER JOHN D JR | 董事 | 买入 | 25,344 | $0 |
| 2026-05-04 | Harsanyi Zsolt | Chairman | 买入 | 25,344 | $0 |
| 2026-05-04 | Zoon Kathryn C | 董事 | 买入 | 25,344 | $0 |
| 2026-05-04 | Zoon Kathryn C | 董事 | 卖出 | 16,145 | $134,972 |
| 2026-05-04 | Zoon Kathryn C | 董事 | 卖出 | 1,057 | $9,481 |
| 2026-05-04 | DeGolyer Donald W | 董事 | 买入 | 25,344 | $0 |
| 2026-05-04 | DeGolyer Donald W | 董事 | 卖出 | 14,527 | $121,446 |
| 2026-05-04 | DeGolyer Donald W | 董事 | 卖出 | 954 | $8,548 |
| 2026-05-01 | PAPA JOSEPH C | President and CEO | 买入 | 187,708 | $0 |
| 2026-05-01 | Perl Jessica | SVP, General Counsel, Corp Sec | 买入 | 104,282 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-10-07